25 clinical trials matched your search for Sarcoma. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Sarcoma A Study for Patients with Malignant Peripheral Nerve Sheath Tumors Using Study Drugs PLX3397 and Sirolimus Gulam Manji, MD, PhD
Sarcoma A Study of the Addition of APX005M to Doxorubicin in Patients with Advanced Sarcoma Matthew Ingham, MD
Sarcoma Study of Paclitaxel With and Without Nivolumab and Nivolumab and Cabozantinib in Taxane Pretreated Subjects with Angiosarcoma Gary Schwartz, MD
Sarcoma Study of Belinostat and Guadecitabine for Treatment of Chondrosarcoma Matthew Ingham, MD
Sarcoma Study of Envafolimab in Patients with Sarcoma or Myxofibrosarcoma Gary Schwartz, MD
Sarcoma A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE) Gary Schwartz, MD
Sarcoma Study of Milademetan in Comparison to Trabectedin in Patients with Liposarcoma Gary Schwartz, MD
Sarcoma Study of INBRX 109 in Patients with Metastatic or Inoperable Chondrosarcoma Matthew Ingham, MD
Sarcoma Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma Gary Schwartz, MD
Sarcoma Study of Drug - CFT8634 in Patients with Synovial Sarcoma or SMARCB1-Null Tumors Gary Schwartz, MD
Sarcoma Study of Drug - BI 907828 in Patients with Dedifferentiated Liposarcoma (DDLPS) Gary Schwartz, MD
Sarcoma Study of Unesbulin in Patients with Leiomyosarcoma (LMS) Matthew Ingham, MD
Cancer Identification of Targets for Cancer Treatment Andrea Califano, PhD
Cancer Study of Atezolizumab in Alveolar Soft Part Sarcoma Gary Schwartz, MD
Cancer Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years) Luca Szalontay, MD
Cancer Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (ages 18-21) Luca Szalontay, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Richard Carvajal, MD
Cancer COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors Benjamin Izar, MD
Cancer Study of GSK3901961 and GSK3845097 in Patients with Synovial Sarcoma or Non-Small Cell Lung Cancer (NSCLC) Matthew Ingham, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Gary Schwartz, MD
Cancer Molecular Analysis for Therapy Choice (MATCH) Richard Carvajal, MD
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Cancer Smartphone App for Cancer Medication Adherence Melissa Accordino, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE